Adagene (ADAG) Invested Capital (2019 - 2026)
Adagene (ADAG) posted quarterly Invested Capital of $711.4 billion for Q4 2025, down 94.5% year-over-year from $12923.6 billion in Q4 2024, and up 15668621.15% quarter-over-quarter from $4.5 million in Q2 2025.
Analysis
Adagene (ADAG) Invested Capital (2019 - 2026) Analysis & Trends
Adagene (ADAG) has reported Invested Capital for 7 consecutive years, with $711.4 billion the latest figure, recorded in Q4 2025.
- In Q4 2025, Invested Capital fell 94.5% year-over-year to $711.4 billion; the TTM figure through Dec 2025 stood at $13635.0 billion (down 30.72% YoY), while the FY2025 annual figure was $711.4 billion, down 94.5% from the prior year.
- Invested Capital climbed to $711.4 billion in Q4 2025 per ADAG's latest filing, from $4.5 million in the prior quarter.
- Across five years, Invested Capital topped out at $12923.6 billion in Q4 2024 and bottomed at $358958.0 in Q4 2021.
- Historically, Invested Capital has averaged $2459.4 billion across 5 years, with a median of $1031.8 billion in 2022.
- Annual changes were most pronounced in 2022 — Invested Capital soared 794000312.3% — and 2024, when it plunged 100.0%.
- Adagene's Invested Capital stood at $358958.0 in 2021, then jumped by 794000312.3% to $2850.1 billion in 2022, then soared by 46.01% to $4161.5 billion in 2023, then soared by 210.55% to $12923.6 billion in 2024, then sank by 94.5% to $711.4 billion in 2025.
- Business Quant data shows ADAG's Invested Capital at $711.4 billion in Q4 2025, $4.5 million in Q2 2025, and $12923.6 billion in Q4 2024.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 33.70 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 7.35 Bn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 6.25 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 19.13 Bn |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1.30 Bn |
| 10 | Adagene | 211.24 Mn | 211.24 Mn | - | 95.18 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 95.18 Mn |
| Dec 31, 2025 | 41.47 Mn |
| Jun 30, 2025 | 44.55 Mn |
| Dec 31, 2024 | 68.73 Mn |
| Jun 30, 2024 | 77.12 Mn |
| Dec 31, 2023 | 92.50 Mn |
| Jun 30, 2023 | 107.73 Mn |
| Dec 31, 2022 | 110.86 Mn |
| Jun 30, 2022 | 129.26 Mn |
| Dec 31, 2021 | 164.05 Mn |
| Jun 30, 2021 | 193.90 Mn |
| Dec 31, 2020 | -81.41 Mn |
| Dec 31, 2019 | -54.45 Mn |